Literature DB >> 21048121

Prospective identification, isolation, and profiling of a telomerase-expressing subpopulation of human neural stem cells, using sox2 enhancer-directed fluorescence-activated cell sorting.

Su Wang1, Devin Chandler-Militello, Gang Lu, Neeta S Roy, Alex Zielke, Romane Auvergne, Nancy Stanwood, Daniel Geschwind, Giovanni Coppola, Silvia K Nicolis, Fraser J Sim, Steven A Goldman.   

Abstract

Sox2 is expressed by neural stem and progenitor cells, and a sox2 enhancer identifies these cells in the forebrains of both fetal and adult transgenic mouse reporters. We found that an adenovirus encoding EGFP placed under the regulatory control of a 0.4 kb sox2 core enhancer selectively identified multipotential and self-renewing neural progenitor cells in dissociates of human fetal forebrain. Upon EGFP-based fluorescence-activated cell sorting (FACS), the E/sox2:EGFP(+) isolates were propagable for up to 1 year in vitro, and remained multilineage competent throughout. E/sox2:EGFP(+) cells expressed more telomerase enzymatic activity than matched E/sox2:EGFP-depleted populations, and maintained their telomeric lengths with successive passage. Gene expression analysis of E/sox2:EGFP-sorted neural progenitor cells, normalized to the unsorted forebrain dissociates from which they derived, revealed marked overexpression of genes within the notch and wnt pathways, and identified multiple elements of each pathway that appear selective to human neural progenitors. Sox2 enhancer-based FACS thus permits the prospective identification and direct isolation of a telomerase-active population of neural stem cells from the human fetal forebrain, and the elucidation of both the transcriptome and dominant signaling pathways of these critically important cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21048121      PMCID: PMC3358973          DOI: 10.1523/JNEUROSCI.1729-10.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  44 in total

1.  EGF converts transit-amplifying neurogenic precursors in the adult brain into multipotent stem cells.

Authors:  Fiona Doetsch; Leopoldo Petreanu; Isabelle Caille; Jose Manuel Garcia-Verdugo; Arturo Alvarez-Buylla
Journal:  Neuron       Date:  2002-12-19       Impact factor: 17.173

2.  The Sox2 regulatory region 2 functions as a neural stem cell-specific enhancer in the telencephalon.

Authors:  Satoru Miyagi; Masazumi Nishimoto; Tetsuichiro Saito; Mikiko Ninomiya; Kazunobu Sawamoto; Hideyuki Okano; Masami Muramatsu; Hideyuki Oguro; Atsushi Iwama; Akihiko Okuda
Journal:  J Biol Chem       Date:  2006-03-16       Impact factor: 5.157

3.  Wnt-mediated self-renewal of neural stem/progenitor cells.

Authors:  M Yashar S Kalani; Samuel H Cheshier; Branden J Cord; Simon R Bababeygy; Hannes Vogel; Irving L Weissman; Theo D Palmer; Roel Nusse
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-28       Impact factor: 11.205

4.  Telomerase activity in human germline and embryonic tissues and cells.

Authors:  W E Wright; M A Piatyszek; W E Rainey; W Byrd; J W Shay
Journal:  Dev Genet       Date:  1996

5.  Human neural precursor cells express low levels of telomerase in vitro and show diminishing cell proliferation with extensive axonal outgrowth following transplantation.

Authors:  T Ostenfeld; M A Caldwell; K R Prowse; M H Linskens; E Jauniaux; C N Svendsen
Journal:  Exp Neurol       Date:  2000-07       Impact factor: 5.330

6.  Stem and progenitor cell-based therapy of the human central nervous system.

Authors:  Steve Goldman
Journal:  Nat Biotechnol       Date:  2005-07       Impact factor: 54.908

7.  bFGF regulates the proliferative fate of unipotent (neuronal) and bipotent (neuronal/astroglial) EGF-generated CNS progenitor cells.

Authors:  A L Vescovi; B A Reynolds; D D Fraser; S Weiss
Journal:  Neuron       Date:  1993-11       Impact factor: 17.173

Review 8.  The neuropoietic cytokine family in development, plasticity, disease and injury.

Authors:  Sylvian Bauer; Bradley J Kerr; Paul H Patterson
Journal:  Nat Rev Neurosci       Date:  2007-03       Impact factor: 34.870

9.  Telomeres shorten during ageing of human fibroblasts.

Authors:  C B Harley; A B Futcher; C W Greider
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

10.  Sox2 regulatory sequences direct expression of a (beta)-geo transgene to telencephalic neural stem cells and precursors of the mouse embryo, revealing regionalization of gene expression in CNS stem cells.

Authors:  M V Zappone; R Galli; R Catena; N Meani; S De Biasi; E Mattei; C Tiveron; A L Vescovi; R Lovell-Badge; S Ottolenghi; S K Nicolis
Journal:  Development       Date:  2000-06       Impact factor: 6.868

View more
  21 in total

1.  Murine maternal dietary restriction affects neural Humanin expression and cellular profile.

Authors:  Claire Baldauf; Monica Sondhi; Bo-Chul Shin; Young Eun Ko; Xin Ye; Kuk-Wha Lee; Sherin U Devaskar
Journal:  J Neurosci Res       Date:  2019-12-15       Impact factor: 4.164

Review 2.  Cellular therapy and induced neuronal replacement for Huntington's disease.

Authors:  Abdellatif Benraiss; Steven A Goldman
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

3.  Zika Virus NS4A and NS4B Proteins Deregulate Akt-mTOR Signaling in Human Fetal Neural Stem Cells to Inhibit Neurogenesis and Induce Autophagy.

Authors:  Qiming Liang; Zhifei Luo; Jianxiong Zeng; Weiqiang Chen; Suan-Sin Foo; Shin-Ae Lee; Jianning Ge; Su Wang; Steven A Goldman; Berislav V Zlokovic; Zhen Zhao; Jae U Jung
Journal:  Cell Stem Cell       Date:  2016-08-11       Impact factor: 24.633

4.  An exploratory investigation of links between changes in adipokines and quality of life in individuals undergoing weight loss interventions: possible implications for cancer research.

Authors:  Faina Linkov; Lora E Burke; Marina Komaroff; Robert P Edwards; Anna Lokshin; Mindi A Styn; Eugene Tseytlin; Kyle E Freese; Dana H Bovbjerg
Journal:  Gynecol Oncol       Date:  2014-01-22       Impact factor: 5.482

5.  CD133/CD140a-based isolation of distinct human multipotent neural progenitor cells and oligodendrocyte progenitor cells.

Authors:  Jing Wang; Melanie A O'Bara; Suyog U Pol; Fraser J Sim
Journal:  Stem Cells Dev       Date:  2013-04-30       Impact factor: 3.272

Review 6.  Transgenic models for investigating the nervous system: Currently available neurofluorescent reporters and potential neuronal markers.

Authors:  Michael Yamakawa; Samuel M Santosa; Neeraj Chawla; Evguenia Ivakhnitskaia; Matthew Del Pino; Sebastian Giakas; Arnold Nadel; Sneha Bontu; Arjun Tambe; Kai Guo; Kyu-Yeon Han; Maria Soledad Cortina; Charles Yu; Mark I Rosenblatt; Jin-Hong Chang; Dimitri T Azar
Journal:  Biochim Biophys Acta Gen Subj       Date:  2020-03-12       Impact factor: 3.770

7.  3K3A-activated protein C stimulates postischemic neuronal repair by human neural stem cells in mice.

Authors:  Yaoming Wang; Zhen Zhao; Sanket V Rege; Min Wang; Gabriel Si; Yi Zhou; Su Wang; John H Griffin; Steven A Goldman; Berislav V Zlokovic
Journal:  Nat Med       Date:  2016-08-22       Impact factor: 53.440

8.  Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination.

Authors:  Su Wang; Janna Bates; Xiaojie Li; Steven Schanz; Devin Chandler-Militello; Corri Levine; Nimet Maherali; Lorenz Studer; Konrad Hochedlinger; Martha Windrem; Steven A Goldman
Journal:  Cell Stem Cell       Date:  2013-02-07       Impact factor: 24.633

9.  An activated protein C analog stimulates neuronal production by human neural progenitor cells via a PAR1-PAR3-S1PR1-Akt pathway.

Authors:  Huang Guo; Zhen Zhao; Qi Yang; Min Wang; Robert D Bell; Su Wang; Nienwen Chow; Thomas P Davis; John H Griffin; Steven A Goldman; Berislav V Zlokovic
Journal:  J Neurosci       Date:  2013-04-03       Impact factor: 6.167

10.  Sox10-MCS5 enhancer dynamically tracks human oligodendrocyte progenitor fate.

Authors:  Suyog U Pol; Jennifer K Lang; Melanie A O'Bara; Thomas R Cimato; Andrew S McCallion; Fraser J Sim
Journal:  Exp Neurol       Date:  2013-03-16       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.